Corvus Pharmaceuticals (CRVS) Institutional Ownership → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free CRVS Stock Alerts $2.28 -0.01 (-0.44%) (As of 03:15 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Corvus Pharmaceuticals (NASDAQ:CRVS)CurrentInstitutional OwnershipPercentage46.64%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$1.36MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$6.98M Get CRVS Insider Trade Alerts Want to know when executives and insiders are buying or selling Corvus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CRVS Institutional Buying and Selling by Quarter Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Corvus Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 BVF Inc. IL361,406$643K0.0%-73.6%0.737% 5/10/2024 Vanguard Group Inc.1,493,357$2.66M0.0%+10.6%3.045% 5/7/2024 Towerview LLC382,500$681K0.5%-12.4%0.780% 2/1/2024 Towerview LLC436,873$769K0.5%+27.6%0.891% 11/13/2023 Connor Clark & Lunn Investment Management Ltd.70,883$103K0.0%-16.0%0.145% 11/4/2023 Towerview LLC342,478$500K0.3%+67.1%0.699% Get the Latest News and Ratings for CRVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/8/2023Tucker Asset Management LLC12,871$29K0.0%N/A0.026% 8/22/2023CHI Advisors LLC200,000$458K0.1%-91.5%0.408% 8/11/2023 MYDA Advisors LLC100,000$229K0.1%N/A0.204% 8/7/2023 Acadian Asset Management LLC58,069$132K0.0%-55.9%0.125% 8/3/2023 Towerview LLC205,000$469K0.3%N/A0.440% 7/27/2023Virtu Financial LLC25,542$58K0.0%+32.0%0.055% 5/11/2023CHI Advisors LLC2,339,402$2.13M0.6%-1.9%5.024% 2/14/2023 Discovery Capital Management LLC CT548,727$466K0.1%N/A1.179% 11/17/2022Telemetry Investments L.L.C.522,009$427K0.5%+13.5%1.121% 10/18/2022 Bailard Inc.39,998$33K0.0%N/A0.086% 4/20/2022 Jackson Square Capital LLC63,773$105K0.0%N/A0.137% 4/13/2022 Hikari Power Ltd49,959$82K0.0%+150.3%0.107% 2/15/2022 Coastal Bridge Advisors LLC24,000$58K0.0%N/A0.052% 2/14/2022 Point72 Asset Management L.P.795,000$1.92M0.0%+38.3%1.708% 2/10/2022 Acadian Asset Management LLC81,166$194K0.0%+96.9%0.174% 11/22/2021 EcoR1 Capital LLC2,081,077$10.07M0.4%-41.9%4.471% 11/16/2021 Squarepoint Ops LLC19,954$97K0.0%N/A0.043% 11/16/2021 Tang Capital Management LLC3,749,379$18.15M3.8%N/A8.055% 11/16/2021 Two Sigma Investments LP140,455$680K0.0%-54.6%0.302% 11/16/2021 Two Sigma Securities LLC22,789$110K0.0%N/A0.049% 11/16/2021Telemetry Investments L.L.C.196,168$949K1.3%-25.7%0.421% 11/16/2021 VR Adviser LLC3,427,461$16.59M2.1%N/A7.363% 11/16/2021 BVF Inc. IL1,370,947$6.64M0.3%-62.7%2.945% 11/16/2021CHI Advisors LLC165,927$803K0.2%-76.9%0.356% 11/15/2021 Point72 Asset Management L.P.575,000$2.78M0.0%N/A1.235% 11/15/2021 Pura Vida Investments LLC734,268$3.55M0.1%N/A1.577% 11/15/2021 Zacks Investment Management10,000$48K0.0%N/A0.021% 11/12/2021 Affinity Asset Advisors LLC50,000$242K0.1%N/A0.107% 11/12/2021 Renaissance Technologies LLC614,370$2.97M0.0%-6.6%1.320% 11/12/2021 DC Investments Management LLC50,709$245K0.5%N/A0.109% 11/12/2021 MYDA Advisors LLC60,000$290K0.1%N/A0.129% 11/12/2021 Geode Capital Management LLC210,243$1.02M0.0%+10.9%0.452% 11/12/2021 Artal Group S.A.500,000$2.42M0.1%N/A1.074% 11/9/2021 BlackRock Inc.100,451$486K0.0%-23.3%0.216% Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade.11/5/2021 Lindbrook Capital LLC14,000$68K0.0%N/A0.033% 8/17/2021 BVF Inc. IL3,678,626$9.82M0.4%+13.9%8.672% 8/16/2021Telemetry Investments L.L.C.263,975$705K1.0%+6.0%0.622% 8/16/2021 State Street Corp29,600$79K0.0%N/A0.070% 8/13/2021 Renaissance Technologies LLC658,070$1.76M0.0%-0.8%1.551% 8/13/2021 Northern Trust Corp59,262$158K0.0%+56.5%0.140% 8/13/2021 Laurion Capital Management LP59,150$158K0.0%-79.0%0.139% 8/13/2021 Algert Global LLC19,737$53K0.0%-53.9%0.047% 8/13/2021 Natixis27,900$74K0.0%+69.1%0.066% 8/13/2021 Geode Capital Management LLC189,541$506K0.0%+27.4%0.447% 8/13/2021 Vanguard Group Inc.1,109,218$2.96M0.0%+10.9%2.615% 8/12/2021 Dimensional Fund Advisors LP395,829$1.06M0.0%-5.0%0.933% 8/11/2021CHI Advisors LLC719,132$1.92M0.4%+5.9%1.695% 5/18/2021 BVF Inc. IL3,229,426$9.95M0.4%+66.1%8.430% 5/18/2021 Millennium Management LLC99,096$305K0.0%-18.5%0.259% 5/18/2021 Orbimed Advisors LLC8,053,298$24.80M0.2%+19.0%21.021% 5/17/2021 Ikarian Capital LLC100,000$307K0.0%N/A0.261% 5/17/2021 Goldman Sachs Group Inc.30,804$95K0.0%-62.3%0.080% 5/14/2021 Laurion Capital Management LP282,132$869K0.0%N/A0.736% 5/14/2021 Dimensional Fund Advisors LP416,649$1.28M0.0%-4.5%1.088% 5/14/2021 Algert Global LLC42,857$132K0.0%+177.1%0.112% 5/13/2021 Renaissance Technologies LLC663,470$2.04M0.0%-16.8%1.732% 5/12/2021 Northern Trust Corp37,878$116K0.0%+28.6%0.099% 5/12/2021 Geode Capital Management LLC148,834$458K0.0%+34.5%0.388% 5/11/2021 Mercer Global Advisors Inc. ADV10,500$32K0.0%N/A0.027% 5/11/2021 Acadian Asset Management LLC20,936$64K0.0%-77.4%0.055% 5/10/2021 GSA Capital Partners LLP95,613$294K0.0%N/A0.250% 5/10/2021 Bank Julius Baer & Co. Ltd Zurich336,748$1.04M0.0%N/A0.879% 5/7/2021 BlackRock Inc.77,668$239K0.0%+11.3%0.203% 5/4/2021 Envestnet Asset Management Inc.10,500$32K0.0%N/A0.027% 2/18/2021 Truist Financial Corp21,000$75K0.0%N/A0.075% 2/12/2021CHI Advisors LLC490,877$1.75M0.5%-15.8%1.749% 2/10/2021 Renaissance Technologies LLC797,070$2.84M0.0%-8.9%2.840% 2/5/2021 BlackRock Inc.69,810$248K0.0%-56.8%0.249% 1/25/2021Golden Green Inc.19,539$70K0.1%N/A0.070% 11/13/2020 Morgan Stanley32,746$131K0.0%+117.7%0.117% 11/9/2020 Acadian Asset Management LLC157,134$630K0.0%-13.5%0.560% 11/6/2020 BlackRock Inc.161,549$647K0.0%-48.0%0.576% 10/8/2020 Hikari Power Ltd19,959$80K0.0%-67.3%0.071% 9/15/2020 Two Sigma Advisers LP36,880$100K0.0%+27.7%0.132% 8/14/2020 BVF Inc. IL1,742,112$4.74M0.3%-19.2%6.214% 8/5/2020 Russell Investments Group Ltd.39,171$106K0.0%+29.6%0.140% 5/15/2020 Squarepoint Ops LLC24,436$52K0.0%N/A0.087% 5/15/2020 Morgan Stanley32,920$69K0.0%-14.8%0.118% 5/15/2020 Two Sigma Investments LP99,258$209K0.0%-8.6%0.355% 5/15/2020 Two Sigma Advisers LP28,880$61K0.0%+74.2%0.103% 5/13/2020 Connor Clark & Lunn Investment Management Ltd.85,604$181K0.0%+4.7%0.306% 5/6/2020 Russell Investments Group Ltd.30,220$63K0.0%N/A0.108% (Data available from 1/1/2016 forward) CRVS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRVS shares? During the previous two years, 12 institutional investors and hedge funds held shares of Corvus Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($2.66M), Towerview LLC ($681K), BVF Inc. IL ($643K), Discovery Capital Management LLC CT ($466K), CHI Advisors LLC ($458K), Telemetry Investments L.L.C. ($427K), and MYDA Advisors LLC ($229K).Learn more on CRVS's institutional investors. What percentage of Corvus Pharmaceuticals stock is owned by institutional investors? 46.64% of Corvus Pharmaceuticals stock is owned by institutional investors. Learn more on CRVS's institutional investor holdings. Which institutional investors have been buying Corvus Pharmaceuticals stock? The following institutional investors have purchased Corvus Pharmaceuticals stock in the last 24 months: Discovery Capital Management LLC CT ($548.73K), Towerview LLC ($436.87K), Vanguard Group Inc. ($142.72K), MYDA Advisors LLC ($100K), Telemetry Investments L.L.C. ($61.91K), Bailard Inc. ($40.00K), and Tucker Asset Management LLC ($12.87K). How much institutional buying is happening at Corvus Pharmaceuticals? Institutional investors have bought a total of 1,349,287 shares in the last 24 months. This purchase volume represents approximately $1.91M in transactions. Which Corvus Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Corvus Pharmaceuticals stock in the last 24 months: CHI Advisors LLC ($2.18M), BVF Inc. IL ($1.01M), Acadian Asset Management LLC ($73.70K), Towerview LLC ($54.37K), and Connor Clark & Lunn Investment Management Ltd. ($13.49K). How much institutional selling is happening at Corvus Pharmaceuticals? Institutional investors have sold a total of 3,335,503 shares in the last 24 months. This volume of shares sold represents approximately $7.02M in transactions. Related Companies: Citius Pharmaceuticals Major Shareholders PMV Pharmaceuticals Major Shareholders Relmada Therapeutics Major Shareholders Adicet Bio Major Shareholders Cellectar Biosciences Major Shareholders Rezolute Major Shareholders Connect Biopharma Major Shareholders Abeona Therapeutics Major Shareholders Immunic Major Shareholders Allakos Major Shareholders This page (NASDAQ:CRVS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldUrgent Nvidia WarningAltimetryThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corvus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.